Gallentes, Lyca L.

HRN: 19-25-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFUROXIME 1.5GM (VIAL)
07/21/2022
07/28/2022
IVT
1.5gm
Q8H
G2P1 (1001) IUFD, UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: